Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
33M
-
Shares change
-
-167K
-
Total reported value, excl. options
-
$550M
-
Value change
-
-$341K
-
Put/Call ratio
-
2.53
-
Number of buys
-
57
-
Number of sells
-
-46
-
Price
-
$16.66
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q3 2022
120 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q3 2022.
Pulmonx Corp - COMMON STOCK (LUNG) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33M shares
of 40.4M outstanding shares and own 81.85% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (5.43M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.72M shares), VANGUARD GROUP INC (3.15M shares), Champlain Investment Partners, LLC (2.8M shares), BlackRock Inc. (2.47M shares), TimesSquare Capital Management, LLC (1.22M shares), Jefferies Group LLC (1.2M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (923K shares), STATE STREET CORP (843K shares), and PURA VIDA INVESTMENTS, LLC (779K shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.